| 1 | Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations. (Nanchal R, Subramanian R, Karvellas CJ, Hollenberg SM, Peppard WJ, Singbartl K, Truwit J, Al-Khafaji AH, Killian AJ, Alquraini M, Alshammari K, Alshamsi F, Belley-Cote E, Cartin-Ceba R, Dionne JC, Galusca DM, Huang DT, Hyzy RC, Junek M, Kandiah P, Kumar G, Morgan RL, Morris PE, Olson JC, Sieracki R, Steadman R, Taylor B, Alhazzani W) Crit Care Med 2020 Mar;48(3):e173-e191 71 Citations |
| 1 | Comparison of Bleeding Complications between Transplenic versus Transhepatic Access of the Portal Venous System. (Haddad MM, Fleming CJ, Thompson SM, Reisenauer CJ, Parvinian A, Frey G, Toskich B, Andrews JC) J Vasc Interv Radiol 2018 Oct;29(10):1383-1391 21 Citations |
| 6 | Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. (Miura JT, Rilling WS, White SB, Hieb RA, Tutton SM, Patel PJ, Gamblin TC, Hohenwalter EJ) HPB (Oxford) 2015 Aug;17(8):707-12 12 Citations |
| 1 | Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. (Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Soulen MC) J Vasc Interv Radiol 2015 Sep;26(9):1257-65; quiz 1265 52 Citations |
| 1 | Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension. (Yan M, Geyer H, Mesa R, Atallah E, Callum J, Bartoszko J, Yee K, Maganti M, Wong F, Gupta V) Clin Lymphoma Myeloma Leuk 2015 Jan;15(1):e1-5 22 Citations |
| 1 | Midterm follow-up of transjugular intrahepatic portosystemic shunts using polytetrafluoroethylene endografts in children. (Vo NJ, Shivaram G, Andrews RT, Vaidya S, Healey PJ, Horslen SP) J Vasc Interv Radiol 2012 Jul;23(7):919-24 25 Citations |
